Some people believe small doses may improve satiety, reduce cravings, or offer hormonal or metabolic benefits even in normal-weight individuals
Takahashi Y, Nomoto H, Yokoyama H et al (2023) Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: a multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study)
Endocrine 83 , 648658 (2024)
Effects of preservative on the Meibomian gland in glaucoma patients treated with prostaglandin analogues
Tammy B
The NICE guidance explained that through this mechanism the drug makes patients feel full resulting in them eating less and reducing their overall calorie intake